Journals / İstanbul Journal of Pharmacy / 2017 / Cilt: 47 - Sayı: 2

MLH1 -93G>A and I219V polymorphisms are susceptible to increased risk of sporadic colorectal cancer in a Turkish population

Pages
63–67
Publication Date
2017-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results provide novel information for understanding the influence of MLH1 on CRC risk in the Turkish population; however, further studies with a larger number of participants are required.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Öz Colorectal cancer (CRC) comprises approximately 10% of all cancers and is a major cause of cancer-related morbidity and mortality despite current diagnostic and treatment improvements.
📊
Key Findings & Data:MutL homolog 1 (MLH1) is one of the vital DNA repair genes responsible for genomic stability.
💡
Conclusion & Impact:Our results provide novel information for understanding the influence of MLH1 on CRC risk in the Turkish population; however, further studies with a larger number of participants are required.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anahtar Kelimeler MLH1 polymorphism · colorectal cancer · PCR-RFLP

Özet

Öz Colorectal cancer (CRC) comprises approximately 10% of all cancers and is a major cause of cancer-related morbidity and mortality despite current diagnostic and treatment improvements. DNA damage and altered DNA replication through the deregulation of related genes cause genomic instability in sporadic CRC. DNA repair is very complex; many factors play a role to ensure that the restoration of errors occurs during the transfer of genetic material. MutL homolog 1 (MLH1) is one of the vital DNA repair genes responsible for genomic stability. Together with environmental factors, the genetic background may be associated with CRC development; thus, genetic polymorphisms are considered as risk factors. The present prospective case–control study aimed to determine the association between 93G>A and I219V polymorphisms of MLH1 and CRC susceptibility in a Turkish population. The genotyping of 158 patients and 164 age- and sex-matched controls was performed by polymerase chain reaction-restriction fragment length polymorphism. Two variants, 93G>A and I219V, were associated with an increased risk of CRC. Individuals with A allele of 93G>A had an approximately 2-fold risk (OR: 1.92, 95% CI: 1.22–3.04; p<0.01) and those with G allele of I219V had an approximately 3-fold risk (OR: 2.82, 95% CI: 1.76–4.52; p<0.01) of developing CRC. Our results provide novel information for understanding the influence of MLH1 on CRC risk in the Turkish population; however, further studies with a larger number of participants are required.

🔖

Cite This Article

Öztaş, E., Çilingir, U., Akyüz, A., Yanar, H. T., Özhan, G. (2017). MLH1 -93G>A and I219V polymorphisms are susceptible to increased risk of sporadic colorectal cancer in a Turkish population. İstanbul Journal of Pharmacy, Cilt: 47 - Sayı: 2, 63–67. https://ajindex.com/articles/41788

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Abbas T, Keaton MA, Dutta A (2013). Genomic instability in cancer. Cold Spring Harb Perspect Biol 5: a012914. [CrossRef] • Allan JM, Shorto J, Adlard J, Bury J, Coggins R, George R, Katory M, Quirke P, Richman S, Scott D, Scott K, Seymour M, Travis LB, Worrillow LJ, Bishop DT, Cox A (2008). MLH1− 93G> A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int J Cancer 123: 2456-2459. [CrossRef] • Anderson GR (2001). Genomic instability in cancer. Curr Sci 81: 501-507. [CrossRef] • Aykan F (2000). Kolorektal Kanserler. In: Topuz E, Aydiner A and Karadeniz AN (eds.). Klinik Onkoloji, İstanbul Üniversitesi,
  2. Onkoloji Enstitüsü Yayınları, İstanbul, pp 90-95. • Berndt SI, Platz EA, Fallin MD, Thuita LW, Hoffman SC, Helzlsouer KJ (2007). Mismatch repair polymorphisms and the risk of colorectal cancer. Int J Cancer 120: 1548-1554. [CrossRef] • Burmester JK, Suarez BK, Lin JH, Jin CH, Miller RD, Zhang KQ, Salzman SA, Reding DJ, Catalona WJ (2004). Analysis of candidate genes for prostate cancer. Hum Hered 57: 172-178. [CrossRef] • Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Slattery ML (2009). Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut 58: 661-667. [CrossRef] • Curtin NJ (2012). DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer 12: 801-817. [CrossRef] • Fan Y, Wang W, Zhu M, Zhou J, Peng J, Xu L, Hua Z, Gao X, Wang Y (2007). Analysis of hMLH1 missense mutations in East Asian patients with suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 13: 7515-7521. [CrossRef] • Fredriksson H, Ikonen T, Autio V, Matikainen MP, Helin HJ, Tammela TLJ, Koivisto PA, Schleutker J (2006). Identification of germline MLH1 alterations in familial prostate cancer. Eur J Cancer 42: 2802-2806. [CrossRef] • Haggar FA and Boushey RP (2009). Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22: 191-197. [CrossRef] • Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M (2009). The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125: 71-180. [CrossRef] • Kim JC, Roh SA, Koo KH, In HK, Kim HC, Chang SY, Lee KH, Kim JS, Lee HI, Bodmer WF (2004). Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean